The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
Inquire more about this report: http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=217369 .
This is a premium report priced at US$1500 for a single user PDF.
- Procedure volumes data for Wound Care Management Procedures segments Tissue Engineered Skin Substitute Procedures (Synthetic Skin Substitute Procedures, Biosynthetic Skin Substitute Procedures and Biologic Skin Substitute Procedures ((Allograft Cellular and Acellular Procedures) and Xenograft Acellular Procedures), Wound Debridement Procedures and Ostomy Procedures.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.
Reasons to buy
- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.